Hardwyn India Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Hardwyn India Ltd is ₹ 9.08 as of 23 Oct 15:30 . The P/E Ratio of Hardwyn India Ltd is 72 as of March 2023 .The P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd is 0 as of March 2023 . The Market Cap of Hardwyn India Ltd is ₹ 668.81 crore as of March 2023 .The Market Cap of Welcure Drugs & Pharmaceuticals Ltd is ₹ 0 crore as of March 2023 . The revenue of Hardwyn India Ltd for the Jun '26 is ₹ 34.63 crore as compare to the Mar '26 revenue of ₹ 57.47 crore. This represent the decline of -39.74% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Hardwyn India Ltd for the Jun '26 is ₹ 4.53 crore as compare to the Mar '26 ebitda of ₹ 6.04 crore. This represent the decline of -25% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Hardwyn India Ltd changed from ₹ 1.34 crore to ₹ 2.8 crore over 9 quarters. This represents a CAGR of 38.75% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Hardwyn India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Hardwyn India Ltd

Hardwyn India Limited was originally incorporated with the name of Garv Industries Limited as a Limited Company on October 12, 2017.
The Promoter, Mr. Rishu Agarwal was involved in trading of aluminum products in Delhi from 1996 through his H.U.F till 2008.
Another Promoter, Mrs. Daya Bansal managed a proprietorship firm known as 'Indian Sales Corporation' which engaged in the business of fabrics trading from April, 2011 to March, 2013.
The name of the Company was changed to Hardwyn India Limited in January 2020. The Company came up with a Public Issue of 32,00,000 Equity Shares by raising capital aggregating Rs 3.2 Crore in April, 2018. The Company is promoted by Rishu Agarwal and family who have been in this business through family proprietary concerns, proprietary business and through partnership.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Hardwyn India Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Hardwyn India Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Hardwyn India Ltd is 620 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Hardwyn India Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Hardwyn India Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Hardwyn India Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 24, 2026, the Hardwyn India Ltd stock price is INR ₹9.08. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Hardwyn India Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Hardwyn India Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.